BGB-3111-309

Recruiting

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

Beigene Study ID info

BGB-3111-309

ClinicalTrials.gov ID info

EudraCT Number info

2022-501147-32-00

China Drug Trials ID info

CTR20230546

Study Overview

Sex: All

Age: 18 Years / 75 Years

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / 75 Years

No Study Documents